We have located links that may give you full text access.
Rarely reported cases of congenital atresia of nasolacrimal puncta.
BACKGROUND: Nasolacrimal punctal atresia has been rarely reported in the literature. It can occur in isolation or in association with other congenital anomalies.
METHODS: Our three cases, seen within a 6-month period in ambulatory eye care centers, had no associated congenital craniofacial anomalies. Case 1 was a 35-year-old woman, Case 2 was a 51-year-old man, and Case 3 was a 47-year-old man. Cases 1 and 2 were asymptomatic because they were missing only the inferior puncta and no intervention was required. Only Case 3 was missing both upper and lower punctal openings of each eye and thus was symptomatic with epiphora. We are referring this patient for more-invasive intervention, such as probing and silicone intubation.
DISCUSSION: The nasolacrimal apparatus develops during the sixth week of prenatal development as a line of epithelium formed by the overlapping of lateral nasal processes by the maxillary processes. Any abnormality that may occur during this time of development can have profound consequences in facial development. Thus, these cases represent a clinical condition that may be associated with more-serious congenital abnormalities that may require additional intervention. The lack of symptoms by most patients, as exemplified by our patients, probably leads to the under-diagnosis of this clinical entity.
CONCLUSION: Current treatment modalities, theories on etiology, and associated congenital conditions are highlighted in the presentations of these cases.
METHODS: Our three cases, seen within a 6-month period in ambulatory eye care centers, had no associated congenital craniofacial anomalies. Case 1 was a 35-year-old woman, Case 2 was a 51-year-old man, and Case 3 was a 47-year-old man. Cases 1 and 2 were asymptomatic because they were missing only the inferior puncta and no intervention was required. Only Case 3 was missing both upper and lower punctal openings of each eye and thus was symptomatic with epiphora. We are referring this patient for more-invasive intervention, such as probing and silicone intubation.
DISCUSSION: The nasolacrimal apparatus develops during the sixth week of prenatal development as a line of epithelium formed by the overlapping of lateral nasal processes by the maxillary processes. Any abnormality that may occur during this time of development can have profound consequences in facial development. Thus, these cases represent a clinical condition that may be associated with more-serious congenital abnormalities that may require additional intervention. The lack of symptoms by most patients, as exemplified by our patients, probably leads to the under-diagnosis of this clinical entity.
CONCLUSION: Current treatment modalities, theories on etiology, and associated congenital conditions are highlighted in the presentations of these cases.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app